IFNA1 and systemic lupus erythematosus: The fact that patients with SLE have an increased level of IFN was described long before genome-wide expression analysis become available, showing that 50%–70% of adult patients and up to 90% of paediatric SLE population have an increased expression of type I IFN—regulated genes, known as IFN signature.